MC
Margarita Chavez
Venture Partner at Wellington Life Science Partners
Chicago, Illinois
Overview
Margarita Chavez is a seasoned biotech executive and investor currently serving as a Board Member at various biotech companies. With a strong background in the pharmaceutical industry and experience at AbbVie Ventures, she has successfully invested in companies like Carisma Therapeutics and Nitrase Therapeutics, contributing to their growth and development. Chavez's career highlights include her roles at Aligos Therapeutics and Newron Pharmaceuticals SpA, showcasing her expertise in early-stage investments and board-level strategic guidance within the biotechnology sector.
Work Experience
Board Member
2024 - Current
Aligos Therapeutics is discovering and developing new classes of molecules that interact directly with disease-causing modalities.
Raised $400,600,000.00 from Deep Track Capital, EcoR1 Capital, Armistice Capital, Lawrence Blatt and Roche Venture Fund.
Board Member
2024
Chair, BD Committee; Member Audit Committe, R&D Committee
Board Advisor
2023 - 2024
Venture Partner
2023
Member Board of Regents
2022
Board Member
2020
P33 is a nonprofit organization for talent, education, capital, finance, business, community, culture, government and infrastructures.
Raised $3,000,000.00 from Minority Business Development Agency.
Board Member
2020 - 2023
ReAx Biotechnologies uses chemical proteomics to discover small molecule drugs, expanding the targetable proteome.
Board Member
2020 - 2023
Board Member
2020 - 2023
Board Member
2020 - 2023
Managing Director, AbbVie Ventures
2016 - 2023
AbbVie is a pharmaceutical company that discovers, develops, and markets medicines.
Raised $15,000,249,999.00.